Accepted for Publication: October 30, 2021.
Published: December 23, 2021. doi:10.1001/jamanetworkopen.2021.40839
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Sharif MA et al. JAMA Network Open.
Corresponding Author: Marissa A. Sharif, PhD, Marketing Department, Wharton School of the University of Pennsylvania, 3730 Walnut Ave, Philadelphia, PA 19104 (masharif@wharton.upenn.edu).
Author Contributions: Ms Bair had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Sharif, Dixon, Garzon, Gibson, Volpp.
Acquisition, analysis, or interpretation of data: Sharif, Bair, Gibson, Linn.
Drafting of the manuscript: Sharif, Dixon.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Sharif, Bair.
Obtained funding: Dixon, Volpp.
Administrative, technical, or material support: Sharif, Dixon, Garzon, Volpp.
Supervision: Sharif, Dixon.
Conflict of Interest Disclosures: Dr Volpp reported being a part owner of VALHealth, a behavioral economics consulting firm; receiving research funding from Hawaii Medical Services Association, Humana, CVS, WW, and Vitality/Discovery; and receiving personal fees from Tandigm, Lehigh Valley Medical Center, Vizient, and the Center for Corporate Innovation. No other disclosures were reported.
Funding/Support: This study was supported by the Pennsylvania Department of Health for research involving COVID Alert PA, the exposure notification app for the Commonwealth of Pennsylvania.
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Trial Registration: ClinicalTrials.gov Identifier: NCT05080179
Data Sharing Statement: See Supplement 3.
1.Ferretti
L , Wymant
C , Kendall
M ,
et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing.
Science. 2020;368(6491):eabb6936. doi:
10.1126/science.abb6936
PubMedGoogle Scholar